We are live on ! Find out more
MSAC

Medicus Sciences Acquisition Corp. Class A Ordinary Share

Delisted

MSAC was delisted on the 17th of February, 2023.

54 hedge funds and large institutions have $104M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

4% more capital invested

Capital invested by funds: $99.4M → $104M (+$4.12M)

0% more funds holding

Funds holding: 5454 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
54
Holders Change
Holders Change %
0%
% of All Funds
0.91%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
11
Reduced
10
Closed
6
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
CCA
26
Cruiser Capital Advisors
Connecticut
$904K
Goldman Sachs
27
Goldman Sachs
New York
$898K +$721K +73,573 +404%
AC
28
Ayrton Capital
Connecticut
$730K
AGM
29
Alpine Global Management
New York
$490K
RCM
30
Rivernorth Capital Management
Florida
$490K
Ohio Public Employees Retirement System (OPERS)
31
Ohio Public Employees Retirement System (OPERS)
Ohio
$489K +$452K +46,100 +1,182%
SSA
32
Schonfeld Strategic Advisors
New York
$439K +$50.5K +5,151 +13%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$379K +$202K +20,659 +115%
HighTower Advisors
34
HighTower Advisors
Illinois
$348K -$49K -5,000 -12%
HF
35
HRT Financial
New York
$340K -$5.85K -597 -2%
PCM
36
Pinz Capital Management
New York
$320K +$321K +32,706 New
OMC
37
Old Mission Capital
Illinois
$315K +$316K +32,200 New
Millennium Management
38
Millennium Management
New York
$308K -$87.5K -8,931 -22%
RCM
39
Robinson Capital Management
Michigan
$306K +$11.8K +1,206 +4%
Verition Fund Management
40
Verition Fund Management
Connecticut
$245K
LC
41
Littlejohn & Co
Connecticut
$196K
CCM
42
CAAS Capital Management
New York
$195K +$195K +19,900 New
WAM
43
Wolverine Asset Management
Illinois
$168K +$169K +17,279 New
GCIA
44
Gabelli & Co Investment Advisers
New York
$151K
GF
45
Gabelli Funds
New York
$143K
E
46
Ergoteles
New York
$133K
CCM
47
Condor Capital Management
New Jersey
$125K -$2.35K -240 -2%
EFI
48
EHP Funds Inc
Canada
$121K +$122K +12,406 New
RCM
49
Radcliffe Capital Management
Pennsylvania
$116K
MIG
50
Mariner Investment Group
New York
$98K

MSAC Hedge Fund Activity: Q2 2022 in Review

54 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q2 2022, worth a combined $104M — up 4.1% from $99.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new MSAC positions and 6 closed out — a net gain of 1 holder — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Glazer Capital LLC, adding an estimated $4.65M. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $2.93M sold.

  • 54 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $104M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q2 2022, up 4.1% quarter-over-quarter.
  • 7 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q2 2022 and 6 closed out, a net change of +1 holder.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q2 2022 was Glazer Capital LLC, an estimated $4.65M added.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q2 2022 was Affinity Asset Advisors, an estimated $2.93M sold.

Based on aggregated 13F filings for Q2 2022.